85 related articles for article (PubMed ID: 12187087)
1. The Decorin gene 179 allelic variant is associated with a slower progression of renal disease in patients with type 1 diabetes.
De Cosmo S; Tassi V; Thomas S; Piras GP; Trevisan R; Cavallo Perin P; Bacci S; Zucaro L; Cisternino C; Trischitta V; Viberti GC
Nephron; 2002 Sep; 92(1):72-6. PubMed ID: 12187087
[TBL] [Abstract][Full Text] [Related]
2. A PC-1 amino acid variant (K121Q) is associated with faster progression of renal disease in patients with type 1 diabetes and albuminuria.
De Cosmo S; Argiolas A; Miscio G; Thomas S; Piras GP; Trevisan R; Perin PC; Bacci S; Zucaro L; Margaglione M; Frittitta L; Pizzuti A; Tassi V; Viberti GC; Trischitta V
Diabetes; 2000 Mar; 49(3):521-4. PubMed ID: 10868979
[TBL] [Abstract][Full Text] [Related]
3. PC-1 amino acid variant (K121Q) has no impact on progression of diabetic nephropathy in type 1 diabetic patients.
Jacobsen P; Grarup N; Tarnow L; Parving HH; Pedersen O
Nephrol Dial Transplant; 2002 Aug; 17(8):1408-12. PubMed ID: 12147787
[TBL] [Abstract][Full Text] [Related]
4. Deletion insertion polymorphism of the angiotensin converting enzyme gene and progression of diabetic nephropathy.
Björck S; Blohmé G; Sylvén C; Mulec H
Nephrol Dial Transplant; 1997; 12 Suppl 2():67-70. PubMed ID: 9269704
[TBL] [Abstract][Full Text] [Related]
5. ACE, PAI-1, decorin and Werner helicase genes are not associated with the development of renal disease in European patients with type 1 diabetes.
De Cosmo S; Margaglione M; Tassi V; Garrubba M; Thomas S; Olivetti C; Piras GP; Trevisan R; Vedovato M; Cavallo Perin P; Bacci S; Colaizzo D; Cisternino C; Zucaro L; Di Minno G; Trischitta V; Viberti GC
Diabetes Metab Res Rev; 1999; 15(4):247-53. PubMed ID: 10495473
[TBL] [Abstract][Full Text] [Related]
6. Decorin deficiency enhances progressive nephropathy in diabetic mice.
Williams KJ; Qiu G; Usui HK; Dunn SR; McCue P; Bottinger E; Iozzo RV; Sharma K
Am J Pathol; 2007 Nov; 171(5):1441-50. PubMed ID: 17884968
[TBL] [Abstract][Full Text] [Related]
7. Glu298Asp and NOS4ab polymorphisms in diabetic nephropathy.
Möllsten A; Wessman M; Svensson M; Forsblom C; Parkkonen M; Brismar K; Groop PH; Dahlquist G
Ann Med; 2006; 38(7):522-8. PubMed ID: 17101543
[TBL] [Abstract][Full Text] [Related]
8. The role of PC-1 and ACE genes in diabetic nephropathy in type 1 diabetic patients: evidence for a polygenic control of kidney disease progression.
De Cosmo S; Miscio G; Zucaro L; Margaglione M; Argiolas A; Thomas S; Piras G; Trevisan R; Perin PC; Bacci S; Frittitta L; Pizzuti A; Tassi V; Di Minno G; Viberti G; Trischitta V
Nephrol Dial Transplant; 2002 Aug; 17(8):1402-7. PubMed ID: 12147786
[TBL] [Abstract][Full Text] [Related]
9. [Diabetic nephropathy: significance of microalbuminuria and proteinuria in Type I and Type II diabetes mellitus].
Lehmann R; Spinas GA
Praxis (Bern 1994); 1995 Oct; 84(44):1265-71. PubMed ID: 7491450
[TBL] [Abstract][Full Text] [Related]
10. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.
Steinke JM; Mauer M;
Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():958-63. PubMed ID: 18806710
[TBL] [Abstract][Full Text] [Related]
11. Remission and regression in the nephropathy of type 1 diabetes when blood pressure is controlled aggressively.
Hovind P; Rossing P; Tarnow L; Smidt UM; Parving HH
Kidney Int; 2001 Jul; 60(1):277-83. PubMed ID: 11422762
[TBL] [Abstract][Full Text] [Related]
12. Polymorphisms in the nephrin gene and diabetic nephropathy in type 1 diabetic patients.
Pettersson-Fernholm K; Forsblom C; Perola M; Groop PH;
Kidney Int; 2003 Apr; 63(4):1205-10. PubMed ID: 12631336
[TBL] [Abstract][Full Text] [Related]
13. A polymorphism in the angiotensin II type 1 receptor gene has different effects on the risk of diabetic nephropathy in men and women.
Möllsten A; Vionnet N; Forsblom C; Parkkonen M; Tarnow L; Hadjadj S; Marre M; Parving HH; Groop PH
Mol Genet Metab; 2011 May; 103(1):66-70. PubMed ID: 21316998
[TBL] [Abstract][Full Text] [Related]
14. Urinary sulphate excretion and progression of diabetic nephropathy in Type 1 diabetes.
Andrésdóttir G; Bakker SJ; Hansen HP; Parving HH; Rossing P
Diabet Med; 2013 May; 30(5):563-6. PubMed ID: 23324103
[TBL] [Abstract][Full Text] [Related]
15. Dinucleotide repeat polymorphism of matrix metalloproteinase-9 gene is associated with diabetic nephropathy.
Maeda S; Haneda M; Guo B; Koya D; Hayashi K; Sugimoto T; Isshiki K; Yasuda H; Kashiwagi A; Kikkawa R
Kidney Int; 2001 Oct; 60(4):1428-34. PubMed ID: 11576356
[TBL] [Abstract][Full Text] [Related]
16. [Polymorphism of aldose reductase gene and susceptibility to retinopathy and nephropathy in Caucasians with type 1 diabetes].
Fanelli A; Hadjadj S; Gallois Y; Fumeron F; Betoule D; Grandchamp B; Marre M
Arch Mal Coeur Vaiss; 2002; 95(7-8):701-8. PubMed ID: 12365083
[TBL] [Abstract][Full Text] [Related]
17. Cellular basis of diabetic nephropathy: V. Endoglin expression levels and diabetic nephropathy risk in patients with Type 1 diabetes.
Alvarez-Muñoz P; Mauer M; Kim Y; Rich SS; Miller ME; Russell GB; Lopez-Novoa JM; Caramori ML
J Diabetes Complications; 2010; 24(4):242-9. PubMed ID: 19395281
[TBL] [Abstract][Full Text] [Related]
18. The influence of sex on renal function decline in people with Type 2 diabetes.
de Hauteclocque A; Ragot S; Slaoui Y; Gand E; Miot A; Sosner P; Halimi JM; Zaoui P; Rigalleau V; Roussel R; Saulnier PJ; Hadjadj Samy S;
Diabet Med; 2014 Sep; 31(9):1121-8. PubMed ID: 24773061
[TBL] [Abstract][Full Text] [Related]
19. The PPARγ2 Pro12Ala variant is protective against progression of nephropathy in people with type 2 diabetes.
Lapice E; Monticelli A; Cocozza S; Pinelli M; Cocozza S; Bruzzese D; Riccardi G; Vaccaro O
J Transl Med; 2015 Mar; 13():85. PubMed ID: 25889595
[TBL] [Abstract][Full Text] [Related]
20. Treatment of diabetic nephropathy with angiotensin II receptor antagonist.
Lewis EJ; Lewis JB
Clin Exp Nephrol; 2003 Mar; 7(1):1-8. PubMed ID: 14586737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
